Acadian Asset Management
TNGX icon

Acadian Asset Management’s Tango Therapeutics TNGX Stock Holding History

Acadian Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Buy
+610
New +$15.1K ﹤0.01% 1931
2025
Q3 		– Sell
-81,953
Closed -$419K – 2007
2025
Q2 		$419K Sell
81,953
-891,356
-92% -$2.2M ﹤0.01% 1174
2025
Q1 		$1.33M Buy
973,309
+478,203
+97% +$1.17M ﹤0.01% 862
2024
Q4 		$1.53M Buy
+495,106
New +$2.3M ﹤0.01% 837

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Acadian Asset Management's TNGX Position: Q2 2026 in Review

Acadian Asset Management opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 610 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #1931 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in TNGX as recently as Q2 2025.

Acadian Asset Management first reported a position in TNGX in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.53M in Q4 2024. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Acadian Asset Management held 610 shares of Tango Therapeutics worth $19K as of Q2 2026.
  • Tango Therapeutics was a new Acadian Asset Management position in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1931 holding.
  • Acadian Asset Management first reported a position in Tango Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • Acadian Asset Management's Tango Therapeutics position peaked at $1.53M in Q4 2024.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.